Selected article for: "cell surface and virus envelope"

Author: Ranjbar, Shahin; Haridas, Viraga; Jasenosky, Luke D.; Falvo, James V.; Goldfeld, Anne E.
Title: A Role for IFITM Proteins in Restriction of Mycobacterium tuberculosis Infection
  • Document date: 2015_10_22
  • ID: zy82bo7q_2
    Snippet: Virus restriction by individual IFITMs depends both on cell type and the intracellular location of each family member. For example, HIV, which undergoes viral envelope-cell membrane fusion at the cell surface or within early endosomes, is more restricted by IFITM1 (Lu et al., 2011) , while influenza A virus, which requires pH-dependent changes in envelope glycoprotein conformation for viral fusion at late endosomes/lysosomes, is more restricted b.....
    Document: Virus restriction by individual IFITMs depends both on cell type and the intracellular location of each family member. For example, HIV, which undergoes viral envelope-cell membrane fusion at the cell surface or within early endosomes, is more restricted by IFITM1 (Lu et al., 2011) , while influenza A virus, which requires pH-dependent changes in envelope glycoprotein conformation for viral fusion at late endosomes/lysosomes, is more restricted by IFITM2/3 (Brass et al., 2009; Desai et al., 2014; Feeley et al., 2011; John et al., 2013) . IFITMs appear to block viral infection by reducing host membrane fluidity at sites of viral fusion through self-interactions and/or interactions with nearby transmembrane proteins, leading to inhibition of viral fusion pore formation and increased trafficking of trapped viruses to the lysosome for degradation (Desai et al., 2014; Lin et al., 2013) .

    Search related documents:
    Co phrase search for related documents
    • late endosome and lysosome late endosome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • late endosome and transmembrane protein: 1, 2, 3
    • late endosome and viral fusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • late endosome and viral infection: 1, 2, 3, 4, 5
    • late endosome and virus restriction: 1
    • lysosome late endosome and transmembrane protein: 1
    • lysosome late endosome and viral fusion: 1, 2, 3, 4
    • lysosome late endosome and viral infection: 1, 2
    • self interaction and viral infection: 1, 2, 3
    • transmembrane protein and viral envelope cell membrane fusion: 1, 2
    • transmembrane protein and viral fusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
    • transmembrane protein and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
    • transmembrane protein and viral infection block: 1
    • transmembrane protein and virus restriction: 1, 2, 3, 4, 5, 6
    • viral fusion and virus restriction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • viral fusion pore and virus restriction: 1
    • viral fusion site and virus restriction: 1
    • viral infection and virus restriction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13